Lynestrenol

Lynestrenol

Lynestrenol
Systematic (IUPAC) name
(8R,9R,10R,13S,14S,17S)-17-ethynyl-13-methyl-
2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-
1H-cyclopenta[a]phenanthren-17-ol
Clinical data
AHFS/Drugs.com
Identifiers
CAS Registry Number  Y
ATC code G03 G03;
G03 G03 G03 G03 (combinations with estrogens)
PubChem CID:
ChemSpider  Y
UNII  Y
KEGG  Y
Chemical data
Formula C20H28O
Molecular mass 284.436 g/mol
 Y   

Lynestrenol is a progestogen hormone. It is a synthetic orally-available progestagen associated with numerous effects of the natural progesterone hormone. Lynestrenol has a strong progestational effect on the uterine endometrium (transforming proliferative endometrium into secretory one), inhibits secretion of gonadotropin, suppresses maturation of follicles in the ovaries and ovulation, reduces menstrual bleeding. This synthetic gestagen is associated with minimal estrogenic, androgenic and anabolic effects. Lynestrenol is used in treatment of hormonal disorders and diseases caused by insufficient secretion of the natural progesterone, except in case of risky pregnancies and prevention of miscarriage, since it is not efficient enough in this indication.

Contents

  • Synthesis 1
    • Positional isomers 1.1
  • Pharmacology 2
  • See also 3
  • References 4

Synthesis

Lynestrenol synthesis:[1][2]

In another approach to analogs, nortestosterone (1) is first converted to the dithioketal (2) by treatment with dithioglycol in the presence of boron trifluoride. (The mild conditions of this reaction compared to those usually employed in preparing the oxygen ketals probably accounts for the double bond remaining at 4,5). Treatment of this derivative with sodium in liquid ammonia affords the 3-desoxy analog (3). Oxidation by means of Jones reagent followed by ethynylation of the 17 ketone leads to the orally active progestin (6).

Positional isomers

These are easily muddled and confused.

ORGANON LABOR LTD).

Pharmacology

After oral administration lynestrenol is quickly resorbed and converted into pharmacologically active norethisterone, through which it demonstrates the main biological effects. The peak blood are reached within 2–4 hours after oral administration, 97% of the administered dose being bound to plasma proteins. Lynestrenol and its metabolites are predominantly excreted in the urine, less through feces, active metabolite norethisterone elimination halftime being 16-17 h.

See also

References

  1. ^ M. S. de Winter, C. M. Siegmann and S. A. Szpilfogel, Chem. Ind. , 905 (1959).
  2. ^ http://www.chemspider.com/Search.aspx?q=Cingestol